ITC Blocks Chinese Biotech Imports In Win For Ventria
The U.S. International Trade Commission has blocked four biotechnology companies from importing a vaccine ingredient from China that infringes a cell culture patent held by Ventria Bioscience....To view the full article, register now.
Already a subscriber? Click here to view full article